Ultrastructural changes induced in cutaneous collagen by ultraviolet-A1 and psoralen plus ultraviolet A therapy in systemic sclerosis

Journal of Dermatology

Volumn 35, Issue 2, 2008, Pages 63-69

  Sakakibara, Noriyuki ^a   Sugano, Shigeru ^a   Morita, Akimichi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Collagen fibril; Psoralen plus ultraviolet A (PUVA); Systemic sclerosis; Ultraviolet A1 (UVA1)

Indexed keywords

COLLAGEN FIBER; METHOXSALEN;

ADULT; AGED; ARTICLE; CELL SIZE; CELL ULTRASTRUCTURE; CLINICAL TRIAL; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DERMIS; EPIDERMIS CELL; FEMALE; HUMAN; LIGHT ABSORPTION; MALE; PUVA; SKIN BIOPSY; SWEAT GLAND; SYSTEMIC SCLEROSIS; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT REFUSAL; ULTRAVIOLET A RADIATION; ULTRAVIOLET RADIATION;

ADULT; AGED; COHORT STUDIES; COLLAGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; PUVA THERAPY; SCLERODERMA, SYSTEMIC; SKIN;

EID: 38949188923     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2008.00417.x     Document Type: Article

References (18)

1. Blann AD, Illingworth K, Jayson MI. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993 20 : 1325 1330.
2. Gustafsson R, Totterman TH, Klareskog L, Hallgren R. Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis 1990 49 : 40 45.
3. Mauch C, Eckes B, Hunzelmann N et al. Control of fibrosis in systemic scleroderma. J Invest Dermatol 1993 100 : 92S 96S.
4. LeRoy EC, Black C, Fleishmajor R et al. Scleroderma (systemic sclerosis). J Rheumatol 1988 15 : 202 205.
5. Black MM, Bottoms E, Shuster S. Skin collagen content and thickness in systemic sclerosis. Br J Dermatol 1970 83 : 552 555.
6. Morita A, Sakakibara S, Sakakibara, N, Yamauchi R, Tsuji T. Successful treatment of systemic sclerosis with topical PUVA. J Rheumatol 1995 22 : 2361 2365.
7. Stege H, Berneburg M, Humke S et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997 36 : 938 944.
8. Rook AH, Freundlich B, Jegasothy BV et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Arch Dermatol 1992 128 : 337 346.
9. Edelson R, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med 1987 316 : 297 303.
10. Morita A, Kobayashi K, Isomura I, Tsuji T, Krutmann J. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000 43 : 670 674.
11. Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblast. Arthritis Rheum 1998 41 : 2039 2047.
12. Yin L, Yamauchi R, Tsuji T, Krutmann J, Morita A. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to the glutathione (GAH) content in skin fibroblasts of systemic sclerosis. J Dermatol 2003 30 : 173 180.
13. Fleishmajer R, Damiano V, Nedwich A. Alteration of subcutaneous tissue in systemic scleroderma. Arch Derm 1972 105 : 59 66.
14. Braun-Falco O, Rupec M. Collagen fibrils of the scleroderma in ultra-thin skin sections. Nature 1964 202 : 708 709.
15. Zelickson AS. Ultrastructure of Normal and Abnormal Skin. Philadelphia, PA : Lea & Febiger, 1967 : 242 243
16. Fleishmajer R, Prunieras M. Generalized morphea: electron microscopy of collagen, cells, and the subcutaneous tissue. Arch Derm 1972 106 : 515 524.
17. Mensing H, Schaeg G. Composites' an aberrant structure of the collagen fibril. Dermatologia 1984 168 : 1 9.
18. Fleishmajer R, Gay S, Meigel WN, Perlish JS. Collagen in the cellular and fibrotic stage of scleroderma. Arthritis Rheum 1978 21 : 418 428.